United States · FDA National Drug Code directory
JANUMET XR
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0006-0080_44f3c6c6-160a-4cc8-8961-b4f7200b5ce5
- Product NDC
- 0006-0080
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- sitagliptin and metformin hydrochloride
- Labeler
- Merck Sharp & Dohme LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20120202
- Source listing expiry
- 20271231
Source-listed ingredients
- SITAGLIPTIN PHOSPHATE — 50 mg/1
- METFORMIN HYDROCHLORIDE — 1000 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 2 BOTTLE in 1 CARTON (0006-0080-28) / 14 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0006-0080-14) · 0006-0080-28
- 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0006-0080-61) · 0006-0080-61
- 180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0006-0080-62) · 0006-0080-62
- 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0006-0080-82) · 0006-0080-82
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →